TickerFacts.

Trevi Therapeutics, Inc. (TRVI): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$42.09M
Year ended 2025-12-31
-$52.63M
Trailing 12 months to 2026-06-30
2018-12-31: -$18.29M2019-12-31: -$23.09M2020-12-31: -$29.00M2021-12-31: -$28.95M2022-12-31: -$28.18M2023-12-31: -$31.71M2024-12-31: -$38.26M2025-12-31: -$42.09M-$42.09M
2018-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$42.09Mn/m2026-03-17, From 2025-01-01
2024-12-31-$38.26Mn/m2026-03-17, From 2024-01-01
2023-12-31-$31.71Mn/m2025-03-18, From 2023-01-01
2022-12-31-$28.18Mn/m2024-03-20, From 2022-01-01
2021-12-31-$28.95Mn/m2023-03-16, From 2021-01-01
2020-12-31-$29.00Mn/m2022-03-17, From 2020-01-01
2019-12-31-$23.09Mn/m2021-03-25, From 2019-01-01
2018-12-31-$18.29Mn/a2020-03-16, From 2018-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Trevi Therapeutics, Inc. (TRVI)2025-12-31-$42.09Mn/m
Adicet Bio, Inc. (ACET)2025-12-31-$95.25Mn/m
Foghorn Therapeutics Inc. (FHTX)2025-12-31-$86.10Mn/m
UroGen Pharma Ltd. (URGN)2025-12-31-$162.44Mn/m
Fortress Biotech, Inc. (FBIO)2025-12-31-$65.78Mn/m
Lexicon Pharmaceuticals, Inc. (LXRX)2025-12-31-$67.85Mn/m
Alto Neuroscience, Inc. (ANRO)2025-12-31-$51.77Mn/m
Benitec Biopharma Inc. (BNTC)2026-06-30-$16.52Mn/m
COMPASS Pathways plc (CMPS)2025-12-31-$157.24Mn/m

Compare TRVI, ACET, FHTX, URGN side by side · Screen every company in Pharmaceutical Preparations ↗